Adagene Stock Fundamentals

ADAG Stock  USD 2.27  0.08  3.65%   
Adagene fundamentals help investors to digest information that contributes to Adagene's financial success or failures. It also enables traders to predict the movement of Adagene Stock. The fundamental analysis module provides a way to measure Adagene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Adagene stock.
At this time, Adagene's Interest Income is most likely to increase significantly in the upcoming years. The Adagene's current Depreciation And Amortization is estimated to increase to about 1.3 M, while Operating Income is projected to decrease to (24.9 M).
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Adagene Company Shares Outstanding Analysis

Adagene's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Adagene Shares Outstanding

    
  44.27 M  
Most of Adagene's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Adagene is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Adagene Shares Outstanding Historical Pattern

Today, most investors in Adagene Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Adagene's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Adagene shares outstanding as a starting point in their analysis.
   Adagene Shares Outstanding   
       Timeline  
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Adagene Common Stock Shares Outstanding

Common Stock Shares Outstanding

44.14 Million

At this time, Adagene's Common Stock Shares Outstanding is most likely to increase significantly in the upcoming years.
Based on the latest financial disclosure, Adagene has 44.27 M of shares currently outstending. This is 75.48% lower than that of the Biotechnology sector and 58.57% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 92.26% higher than that of the company.

Adagene Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Adagene's current stock value. Our valuation model uses many indicators to compare Adagene value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Adagene competition to find correlations between indicators driving Adagene's intrinsic value. More Info.
Adagene is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . At this time, Adagene's Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Adagene by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Adagene Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adagene's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics of similar companies.
Adagene is currently under evaluation in shares outstanding category among its peers.

Adagene ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Adagene's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Adagene's managers, analysts, and investors.
Environmental
Governance
Social

Adagene Fundamentals

About Adagene Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue52.9 K50.2 K
Total Revenue18.1 M19 M
Stock Based Compensation To Revenue 0.40  0.38 
Sales General And Administrative To Revenue 0.48  0.45 
Research And Ddevelopement To Revenue 2.02  1.92 
Revenue Per Share 0.42  0.44 
Ebit Per Revenue(1.31)(1.38)

Currently Active Assets on Macroaxis

When determining whether Adagene is a strong investment it is important to analyze Adagene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adagene's future performance. For an informed investment choice regarding Adagene Stock, refer to the following important reports:
Check out Adagene Piotroski F Score and Adagene Altman Z Score analysis.
For more detail on how to invest in Adagene Stock please use our How to Invest in Adagene guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adagene. If investors know Adagene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adagene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.72)
Revenue Per Share
0.019
Quarterly Revenue Growth
(0.85)
Return On Assets
(0.20)
Return On Equity
(0.46)
The market value of Adagene is measured differently than its book value, which is the value of Adagene that is recorded on the company's balance sheet. Investors also form their own opinion of Adagene's value that differs from its market value or its book value, called intrinsic value, which is Adagene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adagene's market value can be influenced by many factors that don't directly affect Adagene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adagene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Adagene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adagene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.